NEW YORK (Reuters Health) – In postmenopausal women with osteopenia, zoledronic acid, given either once-yearly or as a single infusion, is well tolerated and effective in preventing bone…
NEW YORK (Reuters Health) – Iatrogenic preterm delivery is common among women diagnosed with invasive cancer during pregnancy, a new multicenter study shows. The study, published online in…
NEW YORK (Reuters Health) – Adding a basal or prandial insulin-based regimen to oral therapy may enhance glycemic control in patients with type 2 diabetes, according to a…
NEW YORK (Reuters Health) – Omega-3 fatty acid supplements do not improve the response to sertraline in heart disease patients with major depression, according to results of a…
NEW YORK (Reuters Health) – A secondary analysis of a previous study provides functional data that further supports the benefits of alteplase therapy when given up to 4.5…
NEW YORK (Reuters Health) – Patients with heart failure have fewer hospitalizations and lower mortality when they’re monitored remotely, either by routine telephone calls or electronic transfer of…
NEW YORK (Reuters Health) – Fewer than one third of patients hospitalized for heart failure are treated with aldosterone antagonists, even if they meet eligibility guidelines and are…
NEW YORK (Reuters Health) – Patients taking azathioprine or 6-mercaptopurine for inflammatory bowel disease (IBD) have more than a five-times higher risk of developing a lymphoproliferative disorder compared…
NEW YORK (Reuters Health) – Prophylactic use of acetaminophen during vaccination in children can reduce febrile reactions, but unfortunately the antibody responses to various vaccine antigens are weakened,…
NEW YORK (Reuters Health) – Both low and high levels of adiponectin are associated with an increased risk of death in patients with type 2 diabetes, according to…
